Paracel Explorer

Dernière publication·Octobre 2026

Epclusa

Sofosbuvirum / Velpatasvirum — cpr pell 400/100

Gilead Sciences Switzerland Sàrl

Swissmedic66095

Dossier20566

Remboursement

QP 10%

Modifications (20)